T80.410 Rh incompatibility with acute hemolytic transfusion reaction

Name of the Condition

• Rh incompatibility with acute hemolytic transfusion reaction.

Summary

This condition describes an immune-mediated adverse reaction occurring when Rh-negative individuals receive Rh-positive blood or blood products, leading to acute hemolysis. It results from the recipient’s immune system recognizing Rh antigens as foreign, triggering antibody production and red blood cell destruction. The reaction is acute, with symptoms typically appearing during or shortly after transfusion.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources. The acute nature indicates a rapid immune response.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history. Laboratory tests such as direct antiglobulin testing (Coombs test) or hemoglobin/hematocrit levels may be used to detect hemolysis. Documentation of acute symptoms during or after transfusion is critical.

Treatment Options

Treatment focuses on stopping the transfusion immediately and managing hemolysis. Supportive care includes intravenous fluids, monitoring for renal function, and addressing electrolyte imbalances. In severe cases, additional interventions like dialysis or blood product support may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of hemolysis and promptness of treatment. Most acute reactions resolve with appropriate care, but severe cases can lead to complications. Follow-up includes monitoring for delayed reactions and ensuring Rh status is documented for future transfusions.

Complications

• Acute kidney injury from hemoglobinuria
• Disseminated intravascular coagulation (DIC)
• Hypotension or shock
• Transfusion-related acute lung injury (TRALI)

Lifestyle & Prevention

Prevention involves thorough blood typing and crossmatching before transfusion. Rh-negative individuals should receive Rh-compatible products, and prior sensitization history should be reviewed. Prophylactic Rh immune globulin may be considered in high-risk cases.

When to Seek Professional Help

Seek immediate medical attention if symptoms like fever, chills, or dark urine occur during or after a blood transfusion. Prompt evaluation is essential to prevent severe complications.

Tips for Medical Coders

Document the acute hemolytic nature of the reaction and confirm Rh incompatibility. Include details of the transfusion event, clinical symptoms, and laboratory findings supporting hemolysis. Ensure the code T80.410 is used for initial encounters with acute hemolytic transfusion reactions due to Rh incompatibility.